Renal Denervation Market Growth, Trends, Size, Revenue, Demand and Future Outlook
Renal Denervation Market Size- By Technology - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jan-2025 | Report ID: MEDE2513 | Pages: 1 - 272 | Formats*: |
| Category : Medical Devices | |||
Renal Denervation Market Introduction and Overview
According to SPER Market Research, the Global Renal Denervation Market is estimated to reach USD 14.32 billion by 2034 with a CAGR of 40.49%.
The renal denervation market has expanded due to lifestyle changes that contribute to resistant hypertension and the growing prevalence of hypertension. Moreover, technological advancements, including the development of alternative technologies such as micro-infusion systems for renal denervation, have further driven market growth. The increasing prevalence of hypertension in recent years, which can cause fluctuations in blood pressure and, if persistent, harm the heart and lead to other health complications, has also contributed to the market's expansion. As the incidence of hypertension continues to rise, demand for renal denervation devices is expected to increase. However, the growth of the renal denervation market has been hindered by strict regulatory requirements for devices and limited reimbursement options for treatment.
Recent Development:
- Medtronic announced in November 2023 that their Symplicity Spyral renal denervation (RDN) system, also referred to as the Symplicity blood pressure procedure, has been approved by the U.S. FDA for the treatment of hypertension.
By Technology:
Based on Technology, Radiofrequency-based technology dominated the renal denervation market in 2024, holding a substantial share due to its effectiveness in treating resistant hypertension. Healthcare providers prefer this method because it targets renal nerves to reduce blood pressure through controlled energy delivered to the renal artery walls, disrupting the sympathetic nerves contributing to hypertension. This minimally invasive technique has shown significant promise in clinical trials, leading to widespread adoption and benefiting from its status as one of the first methods developed for renal denervation.
Meanwhile, ultrasound renal denervation is anticipated to experience the fastest growth in the coming years, driven by its improved safety and efficacy. This non-invasive approach uses ultrasound energy to ablate renal nerves without direct contact with arterial walls, reducing the risk of complications. Advances like high-intensity focused ultrasound (HIFU) have enhanced the precision of the procedure. Positive outcomes from recent clinical trials, particularly in reducing blood pressure in resistant hypertension patients, have increased demand for ultrasound-based systems.
By Region:
North America has driven the expansion of the renal denervation market with technological improvements such as improved catheter designs and more precise energy delivery systems, which have increased the procedure's safety and efficacy. Furthermore, large regional enterprises have made significant investments in R&D to introduce novel products. These efforts are bolstered by a favorable regulatory climate, with organizations such as the FDA hastening the clearance process for novel renal denervation devices.
Market Competitive Landscape
The Global Renal Denervation Market is highly consolidated. Some of the market players are Abbott, Ablative Solutions, Inc., Boston Scientific Corporation, Johnson & Johnson Services, Inc., Medtronic, Mercator MedSystems, Inc., Otsuka Medical Devices Co., Ltd., SympleSurgical, Inc., and others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Technology. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Abbott, Ablative Solutions, Inc., Boston Scientific Corporation, Johnson & Johnson Services, Inc., Medtronic, Mercator MedSystems, Inc., Otsuka Medical Devices Co., Ltd., SympleSurgical, Inc., and others. |
Key Topics Covered in the Report:
- Global Renal Denervation Market Size (FY’2021-FY’2034)
- Overview of Global Renal Denervation Market
- Segmentation of Global Renal Denervation Market By Technology (Radiofrequency based, Ultrasound based, Micro-Infusion based)
- Statistical Snap of Global Renal Denervation Market
- Expansion Analysis of Global Renal Denervation Market
- Problems and Obstacles in Global Renal Denervation Market
- Competitive Landscape in the Global Renal Denervation Market
- Details on Current Investment in Global Renal Denervation Market
- Competitive Analysis of Global Renal Denervation Market
- Prominent Players in the Global Renal Denervation Market
- SWOT Analysis of Global Renal Denervation Market
- Global Renal Denervation Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Renal Denervation Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Renal Denervation Market
7. Global Renal Denervation Market, By Technology (USD Million) 2021-2034
7.1. Radiofrequency based7.2. Ultrasound based7.3. Micro-Infusion based
8. Global Renal Denervation Market Forecast, (USD Million) 2021-2034
8.1. Global Renal Denervation Market Size and Market Share
9. Global Renal Denervation Market, By Region, (USD Million) 2021-2034
9.1. Asia-Pacific
9.1.1. Australia9.1.2. China9.1.3. India9.1.4. Japan9.1.5. South Korea9.1.6. Rest of Asia-Pacific
9.2. Europe
9.2.1. France9.2.2. Germany9.2.3. Italy9.2.4. Spain9.2.5. United Kingdom9.2.6. Rest of Europe
9.3. Middle East and Africa
9.3.1. Kingdom of Saudi Arabia9.3.2. United Arab Emirates9.3.3. Qatar9.3.4. South Africa9.3.5. Egypt9.3.6. Morocco9.3.7. Nigeria9.3.8. Rest of Middle-East and Africa
9.4. North America
9.4.1. Canada9.4.2. Mexico9.4.3. United States
9.5. Latin America
9.5.1. Argentina9.5.2. Brazil9.5.3. Rest of Latin America
10. Company Profile
10.1. Abbott
10.1.1. Company details10.1.2. Financial outlook10.1.3. Product summary10.1.4. Recent developments
10.2. Ablative Solutions, Inc.
10.2.1. Company details10.2.2. Financial outlook10.2.3. Product summary10.2.4. Recent developments
10.3. Boston Scientific Corporation
10.3.1. Company details10.3.2. Financial outlook10.3.3. Product summary10.3.4. Recent developments
10.4. Johnson & Johnson Services, Inc.
10.4.1. Company details10.4.2. Financial outlook10.4.3. Product summary10.4.4. Recent developments
10.5. Medtronic
10.5.1. Company details10.5.2. Financial outlook10.5.3. Product summary10.5.4. Recent developments
10.6. Mercator MedSystems, Inc.
10.6.1. Company details10.6.2. Financial outlook10.6.3. Product summary10.6.4. Recent developments
10.7. Otsuka Medical Devices Co., Ltd.
10.7.1. Company details10.7.2. Financial outlook10.7.3. Product summary10.7.4. Recent developments
10.8. SympleSurgical, Inc.
10.8.1. Company details10.8.2. Financial outlook10.8.3. Product summary10.8.4. Recent developments
10.9. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Renal Denervation Market size is USD 14.32 billion from 2025 to 2034.
The North America is anticipated to have the highest Market share in the Renal Denervation Market.
The key players in the Market include Companies Covered Abbott, Ablative Solutions, Inc., Boston Scientific Corporation, Johnson & Johnson Services, Inc., Medtronic, Mercator MedSystems, Inc., Otsuka Medical Devices Co., Ltd., SympleSurgical, Inc., and others.
The renal denervation market has expanded due to lifestyle changes that contribute to resistant hypertension and the growing prevalence of hypertension. Moreover, technological advancements, including the development of alternative technologies such as micro-infusion systems for renal denervation, have further driven market growth.
Renal Denervation Market is projected to reach USD 14.32 billion by 2034, growing at a CAGR of 40.49% during the forecast period.
Renal Denervation Market grew in Market size from 2025. The Market is expected to reach USD 14.32 billion by 2034, at a CAGR of 40.49% during the forecast period.
Renal Denervation Market CAGR of 40.49% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Renal Denervation Market is covered By Technology.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
